Grant: Discovery Grants Program - Individual
University of Calgary
$25,000.00
Interactions between the streptococcal inhibitor of complement (sic) protein and its targets in neutrophils
EF 2008-09
Résumé
The neutrophil is the first and most abundant leukocyte to be delivered to a site of inflammation or infection. Neutrophils are equipped with an antimicrobial arsenal that destroys invading pathogens. However, many pathogens have devised strategies to avoid killing by neutrophils. Streptococcus pyogenes (S. pyogenes) or group A Streptococcus (GAS), a gram-positive bacterium, is one of them. S. pyogenes can cause a variety of human diseases, including pharyngitis (strep throat), cellulites, impetigo, and the potentially fatal necrotizing fascitis (flesh eating disease) and streptococcal toxic shock syndrome. My long-term objective is to understand how S. pyogenes evades killing by neutrophils. My general hypothesis is that exotoxins secreted by S. pyogenes interact with protein components of the neutrophil defense machineries to prevent killing of the microorganism. My specific hypothesis is that a novel protein named sic (streptococcal inhibitor of complement), which is secreted by S. pyogenes, targets specific proteins in neutrophils which regulate its ability to ingest microorganisms (phagocytosis) or secrete microbicidal enzymes. Our specific objectives are to (i) identify and characterize the specific targets of sic in neutrophils and (ii) to analyze the molecular interactions between sic and its protein targets, and examine the molecular effect of sic on secretion and phagocytosis. We will use a combination of modern methodologies in cellular and molecular biology, immunology and biochemistry to pursue our goals, including mass spectrometry, yeast-two hybrid analysis, protein expression and purification, two-dimensional gel electrophoresis, and immunoelectron and confocal microscopy. These investigations will allow us to elucidate the functional significance of the molecular interactions between sic and its protein targets in neutrophils. Thus, our studies will advance our knowledge of S. pyogenes mechanisms that evolved to prevent its destruction by neutrophils.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
356448-2008
Name nom
Rosales, Jesusa
Department département
Biochemistry and Molecular Biology
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2008
Award amount
25000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
1
Nb partie
5
Application title
Interactions between the streptococcal inhibitor of complement (sic) protein and its targets in neutrophils
Keyword
NA
Application summary
The neutrophil is the first and most abundant leukocyte to be delivered to a site of inflammation or infection. Neutrophils are equipped with an antimicrobial arsenal that destroys invading pathogens. However, many pathogens have devised strategies to avoid killing by neutrophils. Streptococcus pyogenes (S. pyogenes) or group A Streptococcus (GAS), a gram-positive bacterium, is one of them. S. pyogenes can cause a variety of human diseases, including pharyngitis (strep throat), cellulites, impetigo, and the potentially fatal necrotizing fascitis (flesh eating disease) and streptococcal toxic shock syndrome. My long-term objective is to understand how S. pyogenes evades killing by neutrophils. My general hypothesis is that exotoxins secreted by S. pyogenes interact with protein components of the neutrophil defense machineries to prevent killing of the microorganism. My specific hypothesis is that a novel protein named sic (streptococcal inhibitor of complement), which is secreted by S. pyogenes, targets specific proteins in neutrophils which regulate its ability to ingest microorganisms (phagocytosis) or secrete microbicidal enzymes. Our specific objectives are to (i) identify and characterize the specific targets of sic in neutrophils and (ii) to analyze the molecular interactions between sic and its protein targets, and examine the molecular effect of sic on secretion and phagocytosis. We will use a combination of modern methodologies in cellular and molecular biology, immunology and biochemistry to pursue our goals, including mass spectrometry, yeast-two hybrid analysis, protein expression and purification, two-dimensional gel electrophoresis, and immunoelectron and confocal microscopy. These investigations will allow us to elucidate the functional significance of the molecular interactions between sic and its protein targets in neutrophils. Thus, our studies will advance our knowledge of S. pyogenes mechanisms that evolved to prevent its destruction by neutrophils.